The Society of Chemical Manufacturers & Affiliates (SOCMA) commends the U.S. Environmental Protection Agency (EPA) on its completion of the Risk Management Plan (RMP) reconsideration rulemaking that was released earlier today.
The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce that Ashland’s Merry Hill facility is being recognized for its tremendous efforts and unique approaches to sustainability practices as part of the association’s 2019 Performance Improvement Awards program during SOCMA Week, December 4-6, in New Orleans.
The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce that ChemDesign is being recognized for its exceptional efforts to educate a new generation about the importance of specialty chemistry as part of the association’s Performance Improvement Awards program.
ARLINGTON, VA – SOCMA is pleased to announce that more than 20 SOCMA member facilities will receive 2019 Performance Improvement Awards. Now in its 13th year, SOCMA continues to honor companies that are leading in the areas of environmental, health, safety and security (EHS&S).
The state of play has reached a critical juncture in U.S.-Mexico-Canada Agreement (USMCA) negotiations (USMCA being the trade agreement that is set to replace NAFTA) as House Democrats continue to work through the thorniest outstanding issues, such as the pact’s labor standards and enforcement mechanism, with the Office of the U.S. Trade Representative.
MFG Chemical, a global leader in specialty and custom chemical manufacturing, has added to its domestic and international customer service and logistics staff.
Edward Price, President & CEO, SEQENS N.A. and member of the Bulk Pharmaceuticals Task Force, an affiliate of SOCMA testified to the Subcommittee on Health of the Committee on Energy and Commerce on October 30.
Edward Price, President and CEO, SEQENS N.A. and a member of SOCMA’s Bulk Pharmaceutical Task Force, today called for reasonable regulations and increased collaboration between stakeholders during testimony before the House Committee on Energy & Commerce hearing on Pharmaceutical Supply Chains in a Global Economy.
SOCMA ChemTrends: Preparing for Customer Audits Paul HirshSenior Vice President, Industry Development and Strategic Partnerships The pace of material sourcing... View Article
Rigid purity and performance demands, costly infrastructure and expertise and economic and global trends often result in a lack of suppliers outside China. And, in the event that alternate sources exist, supplier(s) often lack adequate volume to make up for shortfalls from China and so SOCMA members are placed on insufficient allocation and face price increases that results in the loss of market share to foreign competitors not subject to such taxes on inputs needed to formulate products.